CORAL SPRINGS, Florida, January 16, 2014 /PRNewswire/ --
News updates for NASDAQ companies making strides with financial results, new agreements & distribution opportunities: RiceBran Technologies (NASDAQ: RIBT), Whole Foods Market Inc. (NASDAQ: WFM), The Hain Celestial Group, Inc. (NASDAQ: HAIN), DryShips, Inc. (NASDAQ: DRYS) and Chelsea Therapeutics International Ltd. (NASDAQ: CHTP)
RiceBran Technologies (NASDAQ: RIBT), a global leader in the production and marketing of value added products derived from rice bran, today announced that it has entered into a multi-year distribution and supply agreement with Hela Spice Canada Inc. to sell the Company's stabilized rice bran and rice bran derivative products in Canada. Hela Spice Canada, a member of the Hela Gewurzwerk Herman Laue global network of companies, specializes in the design and formulation of custom blends for the meat, poultry, bakery and other sectors of the food industry. Under the terms of the multi-year Distribution and Supply Agreement, Hela Spice Canada will distribute RiceBran Technologies' RiBran family of stabilized rice bran ingredients and derivatives including RiBalance, RiSolubles and RiFiber throughout Canada.
To read the full press release, please click here: http://www.fnmprofiles.com/profiles-ribt.html
W. John Short, CEO & President of RiceBran Technologies, commented, "We are pleased to continue to strengthen our distribution network through this new alliance with Hela Spice Canada. We believe the Canadian market will be an important driver of future sales growth for our stabilized rice bran and derivative products in the coming years. Hela is a recognized leader in the formulation and supply of ingredients to the meat, poultry, bakery and other sectors of the food industry in Canada, making them a perfect partner for our expansion efforts."
Whole Foods Market Inc. (NASDAQ: WFM) recently announced it will issue financial results for the Company's first fiscal quarter ending January 19, 2014, after the market closes on Wednesday, February 12, 2014. Following the release via the wire services, the Company will host a conference call with financial analysts and investors from 4:00 - 4:30 p.m. (CT). To participate, dial 866-952-1906 (domestic) and 785-424-1825 (international). The conference ID is "Whole Foods." Please dial in at least five minutes before the start of the conference call. A simultaneous audio webcast will be available through a link on the Company's website at http://www.wholefoodsmarket.com/company/index.php. The webcast will be archived for a minimum of 30 days.
The Hain Celestial Group, Inc. (NASDAQ: HAIN) a leading organic and natural products company providing consumers with A Healthier Way of Life™, recently announced the acquisition of Tilda Limited ("Tilda"), a leading premium 100% branded Basmati and specialty rice products company. The Tilda brand offers a range of over 60 dry rice and ready-to-heat branded products under the names Tilda®, Akash® Basmati and Abu Shmagh® to consumers in over 40 countries, principally in the United Kingdom, the Middle East and North Africa ("MENA"), Continental Europe, North America and India.
DryShips, Inc. (NASDAQ: DRYS) a global provider of marine transportation services for drybulk and petroleum cargoes and through its majority owned subsidiary, Ocean Rig UDW Inc. ("Ocean Rig"), of offshore deepwater drilling services, recently announced that it intends to resume sales under its previously announced $200 million program of at the market issuances of its common shares through Evercore Group L.L.C. as its sales agent. To date, the Company has issued 6,892,233 common shares under the program resulting in gross proceeds of $24.1 million.
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) announced that the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 16-1 to recommend approval of NORTHERA™ (droxidopa) for the treatment of symptomatic neurogenic orthostatic hypotension (nOH) in patients with primary autonomic failure (Parkinson's disease, multiple system atrophy and pure autonomic failure), dopamine beta hydroxylase deficiency and non-diabetic autonomic neuropathy. The FDA is not bound by the CRDAC's recommendation but will take it into consideration when reviewing the New Drug Application (NDA) for Northera. A Prescription Drug User Fee Act (PDUFA) action date for the Northera NDA has been scheduled for February 14, 2014.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup. Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PRESS to 545454. (SMS alerts are free, however data rates may apply, check your wireless plan for details.)
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. FNMG has been compensated one thousand five hundred dollars for RiceBran Technologies news coverage by the Company.
FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
SOURCE FN Media Group LLC